EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C28H27NO4S |
| Net Charge | 0 |
| Average Mass | 473.594 |
| Monoisotopic Mass | 473.16608 |
| SMILES | O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12 |
| InChI | InChI=1S/C28H27NO4S/c30-21-8-4-20(5-9-21)28-26(24-13-10-22(31)18-25(24)34-28)27(32)19-6-11-23(12-7-19)33-17-16-29-14-2-1-3-15-29/h4-13,18,30-31H,1-3,14-17H2 |
| InChIKey | GZUITABIAKMVPG-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Chemical Role: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Roles: | antiviral agent A substance that destroys or inhibits replication of viruses. estrogen antagonist A compound which inhibits or antagonises the biosynthesis or actions of estrogens. |
| Applications: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. antipsychotic agent Antipsychotic drugs are agents that control agitated psychotic behaviour, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. estrogen antagonist A compound which inhibits or antagonises the biosynthesis or actions of estrogens. bone density conservation agent An agent that inhibits bone resorption and/or favor bone mineralization and bone regeneration. Used to heal bone fractures and to treat bone diseases such as osteopenia and osteoporosis. estrogen receptor modulator A substance that possess antiestrogenic actions but can also produce estrogenic effects as well. It acts as complete or partial agonist or as antagonist. It can be either steroidal or nonsteroidal in structure. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| raloxifene (CHEBI:8772) has role antineoplastic agent (CHEBI:35610) |
| raloxifene (CHEBI:8772) has role antipsychotic agent (CHEBI:35476) |
| raloxifene (CHEBI:8772) has role antiviral agent (CHEBI:22587) |
| raloxifene (CHEBI:8772) has role bone density conservation agent (CHEBI:50646) |
| raloxifene (CHEBI:8772) has role estrogen antagonist (CHEBI:50837) |
| raloxifene (CHEBI:8772) has role estrogen receptor modulator (CHEBI:50739) |
| raloxifene (CHEBI:8772) is a N-oxyethylpiperidine (CHEBI:48737) |
| raloxifene (CHEBI:8772) is a 1-benzothiophenes (CHEBI:38836) |
| raloxifene (CHEBI:8772) is a aromatic ketone (CHEBI:76224) |
| raloxifene (CHEBI:8772) is a organic molecular entity (CHEBI:50860) |
| raloxifene (CHEBI:8772) is a phenols (CHEBI:33853) |
| raloxifene (CHEBI:8772) is conjugate base of raloxifene(1+) (CHEBI:90191) |
| Incoming Relation(s) |
| raloxifene(1+) (CHEBI:90191) is conjugate acid of raloxifene (CHEBI:8772) |
| IUPAC Name |
|---|
| [6-hydroxy-2-(4-hydroxyphenyl)-1-benzothien-3-yl][4-(2-piperidin-1-ylethoxy)phenyl]methanone |
| INNs | Source |
|---|---|
| raloxifene | ChemIDplus |
| raloxifène | ChEBI |
| raloxifeno | ChemIDplus |
| raloxifenum | ChemIDplus |
| Synonyms | Source |
|---|---|
| (2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone | ChemIDplus |
| Eviden | ChEMBL |
| J22.982B | ChEMBL |
| LY 139481 | KEGG COMPOUND |
| LY-139481 | ChEMBL |
| NSC-747974 | ChEMBL |
| Brand Name | Source |
|---|---|
| Keoxifene | DrugBank |
| Registry Numbers | Sources |
|---|---|
| Beilstein:4890356 | Beilstein |
| CAS:84449-90-1 | ChemIDplus |
| Citations |
|---|